PCV54 THE COST-UTILITY OF ALISKIREN IN THE TREATMENT OF MILD TO MODERATE HYPERTENSION. A CANADIAN HEALTH CARE SYSTEM PERSPECTIVE
Abstract
Authors
A Lee SJ Barry L Leiter A Nanji L Annemans D Tucker AF Michaliszyn M Barbeau G Vincze